This page has beta status

BMBS COST Action B23
Oral facial development and regeneration

The main objective of the Action is to increase and facilitate the understanding of dental and oralfacial

biology by elucidating the molecular basis of normal and abnormal development as well as

tissue regeneration and allowing development of novel clinical approaches.

The Action, whilst complementary to the B8 COST Action, represents a significant advance in the

outcomes as shown within the title. General objectives are focused on the development and

phylogenetic processes, identification of signalling networks and molecules, functions of regulatory

genes and specific proteins, target genes and delivery molecules for prospective therapy.

Finally, the highest specificity of this Action is to set up a unique, multidisciplinary network of

scientists and clinicians and also incorporate a core of European companies that will participate

in the earliest steps of product development.

Secondary objectives will include the understanding and characterisation of issues in:

- neural crest patterning and oral facial development

- molecular, epigenetic and cellular regulation of dental patterning, morphogenesis and cell

differentiation

- phylogenetic and functional constraints in tooth development in various vertebrate lineages

- signalling cascades, signalling molecules and their target genes

- stem cells, their lineage, maintenance and differentiation during hard tissue formation,

degradation and regeneration

- roles of new genes and their mutations during dental / oral facial development

- genetically induced dental / oral facial abnormalities and diseases

- biological repair, biomimetic, biomaterials, tissue regeneration and tissue engineering

- clinical applications

The proposed studies will have significant impact on an essential implication in:

1. Knowledge, therapy and counselling of genetic disorders affecting teeth and oral facial

development.

2. Translation of basic research findings to clinical applications for improved diagnosis and

treatment.

3. Tissue engineering of teeth and surrounding tissues.

(Descriptions are provided by the Actions directly via e-COST.)


General Information*

Chair of the Action:

Prof. Henri MAGLOIRE (FR)

Vice Chair of the Action:

Prof. Ann HUYSSEUNE (BE)

Science officer of the Action:

Dr Inga DADESHIDZE

Administrative officer of the Action:

Ms Gabriela CRISTEA

Downloads*

Action Fact Sheet

Download AFS as .RTF

Tools

Last updated: 02 May 2011 top of page